Healthcare provider profile · identity verified

Lidiya Kupriyenko, MD

Internal Medicine · BUFFALO GROVE, IL · NPI 1942487772

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	457	121
Atorvastatin Calcium	Atorvastatin Calcium	422	127
Rosuvastatin Calcium	Rosuvastatin Calcium	402	116
Metoprolol Succinate	Metoprolol Succinate	329	75
Levothyroxine Sodium	Levothyroxine Sodium	308	72
Losartan Potassium	Losartan Potassium	225	57
Metformin Hcl	Metformin Hcl	198	57
Omeprazole	Omeprazole	177	48
Lisinopril	Lisinopril	134	40
Pantoprazole Sodium	Pantoprazole Sodium	123	32
Hydrochlorothiazide	Hydrochlorothiazide	117	35
Escitalopram Oxalate	Escitalopram Oxalate	115	31
Eliquis	Apixaban	98	25
Allopurinol	Allopurinol	94	28
Simvastatin	Simvastatin	91	26
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	86	20
Gabapentin	Gabapentin	85	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	25
Meloxicam	Meloxicam	81	23
Metoprolol Tartrate	Metoprolol Tartrate	80	22
Potassium Chloride	Potassium Chloride	80	16
Trazodone Hcl	Trazodone Hcl	78	23
Ozempic	Semaglutide	75	13
Atenolol	Atenolol	69	16
Metformin Hcl Er	Metformin Hcl	65	22
Fluticasone Propionate	Fluticasone Propionate	64	32
Tamsulosin Hcl	Tamsulosin Hcl	64	18
Alendronate Sodium	Alendronate Sodium	63	17
Jardiance	Empagliflozin	62	14
Valsartan	Valsartan	62	17
Sertraline Hcl	Sertraline Hcl	59	15
Ezetimibe	Ezetimibe	57	18
Glipizide	Glipizide	56	19
Furosemide	Furosemide	53	22
Carvedilol	Carvedilol	52	15
Triamcinolone Acetonide	Triamcinolone Acetonide	50	21
Enalapril Maleate	Enalapril Maleate	49	13
Olmesartan Medoxomil	Olmesartan Medoxomil	49	12
Famotidine	Famotidine	48	18
Zolpidem Tartrate	Zolpidem Tartrate	47	11
Lorazepam	Lorazepam	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	43	18
Montelukast Sodium	Montelukast Sodium	42	14
Tizanidine Hcl	Tizanidine Hcl	41	18
Doxazosin Mesylate	Doxazosin Mesylate	40	suppressed
Lidocaine	Lidocaine	40	suppressed
Synthroid	Levothyroxine Sodium	40	suppressed
Linzess	Linaclotide	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Torsemide	Torsemide	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	35	12
Prednisone	Prednisone	34	32
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Irbesartan	Irbesartan	31	suppressed
Ketoconazole	Ketoconazole	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Azithromycin	Azithromycin	28	27
Creon	Lipase/Protease/Amylase	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Methylprednisolone	Methylprednisolone	25	24
Hydrocortisone	Hydrocortisone	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Glimepiride	Glimepiride	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Finasteride	Finasteride	22	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	12
Mounjaro	Tirzepatide	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Temazepam	Temazepam	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Nexium	Esomeprazole Magnesium	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error